Interferon-based Simeprevir Therapy for Pediatric Patients with Chronic Hepatitis C Viral Infection.

Interferon-based Simeprevir Therapy for Pediatric Patients with Chronic Hepatitis C Viral Infection. Ann Hepatol. 2018 Aug 24;17(5):756-758 Authors: Suzuki M, Minowa K, Tajiri H Abstract Interferon-based simeprevir therapy showed high efficacy and tolerability in children with genotype 1 hepatitis C virus infection. While direct-acting antivirals (DAAs) therapy are undergoing study in children, this regimen is considered an available therapeutic option for selected patients in countries where DAAs have not yet been approved. PMID: 30145575 [PubMed - in process]
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research